3P Biopharmaceuticals
3P Biopharmaceuticals is a leading Contract Development and Manufacturing Organization (CDMO) specializing in process development and cGMP manufacturing of biologics, cell therapy products, gene therapies, and novel biopharmaceuticals. The company is committed to advancing innovative biopharmaceuticals from laboratory to clinical and commercial phases, supporting clients worldwide with high-quality, flexible, and efficient services. With extensive experience in process development, analytical methods, GMP manufacturing, and regulatory compliance, 3P Biopharmaceuticals aims to improve patient outcomes through the development of safe and effective biological medicines. The company also collaborates with biotech firms such as Affibody AB for the development and manufacturing of therapeutic proteins and vaccines.
Industries
Nr. of Employees
large (251-1000)
3P Biopharmaceuticals
Patents
Products
Biologics CDMO Services
Provides comprehensive services for the development and manufacturing of biologics, including process and analytical development, preclinical and clinical supply, and commercial production.
Mammalian Services
Produces proteins using mammalian cell lines such as CHO, NS0, BHK-21, HEK293, and Hybridoma cells, offering flexibility and experience to meet project needs.
Microbial Services
Produces recombinant proteins using microbial cell lines like E.coli, P. pastoris, S. cerevisiae, H. pylori, and S. noursei, with the ability to use other cell types as required.
Cell Therapy Services
Offers development and manufacturing services for cell therapy products, including technology transfer, process development, cell culture, and GMP certification.
Biologics CDMO Services
Provides comprehensive services for the development and manufacturing of biologics, including process and analytical development, preclinical and clinical supply, and commercial production.
Mammalian Services
Produces proteins using mammalian cell lines such as CHO, NS0, BHK-21, HEK293, and Hybridoma cells, offering flexibility and experience to meet project needs.
Microbial Services
Produces recombinant proteins using microbial cell lines like E.coli, P. pastoris, S. cerevisiae, H. pylori, and S. noursei, with the ability to use other cell types as required.
Cell Therapy Services
Offers development and manufacturing services for cell therapy products, including technology transfer, process development, cell culture, and GMP certification.
Services
Process development, scale‑up, GMP production, downstream purification, analytics and drug product fill for viral vectors across production formats.
GMP plasmid production from E. coli using fed‑batch fermentation, chromatographic purification and identity/topology QC to support transfection and clinical manufacturing.
Technical transfer of production processes and analytics, non‑GMP and GMP manufacture of recombinant proteins, analytical method validation, aseptic fill/finish and stability studies for clinical trial supply.
Automated aseptic filling, visual inspection, labeling, packaging, intermediate storage, stability management and qualified person batch release for biologic drug products.
Comprehensive analytical testing, method development and validation, in‑process control analytics and stability studies for biologics, viral vectors and plasmids to support regulatory submissions and batch release.
Technical transfer, execution of engineering and consistency batches, process optimisation and scale‑up to GMP production volumes with process documentation suitable for regulatory dossiers.
Process development, scale‑up, GMP production, downstream purification, analytics and drug product fill for viral vectors across production formats.
GMP plasmid production from E. coli using fed‑batch fermentation, chromatographic purification and identity/topology QC to support transfection and clinical manufacturing.
Technical transfer of production processes and analytics, non‑GMP and GMP manufacture of recombinant proteins, analytical method validation, aseptic fill/finish and stability studies for clinical trial supply.
Automated aseptic filling, visual inspection, labeling, packaging, intermediate storage, stability management and qualified person batch release for biologic drug products.
Comprehensive analytical testing, method development and validation, in‑process control analytics and stability studies for biologics, viral vectors and plasmids to support regulatory submissions and batch release.
Technical transfer, execution of engineering and consistency batches, process optimisation and scale‑up to GMP production volumes with process documentation suitable for regulatory dossiers.
Expertise Areas
- CDMO project management and integrated service delivery
- Viral vector development and GMP manufacture
- Recombinant protein process development and clinical manufacturing
- GMP plasmid DNA production
Key Technologies
- Adeno‑associated virus (AAV) production
- Adenovirus and lentivirus production
- Plasmid DNA production by fed‑batch microbial fermentation
- Single‑use bioreactors (laboratory to 200 L class)
News & Updates
An overview of AAV vector production, advantages, plasmid requirements, production methods, purification, QC, and timelines, provided by 3P Biopharmaceuticals.
An overview of AAV vector production, advantages, plasmid requirements, production methods, purification, QC, and timelines, provided by 3P Biopharmaceuticals.